Teva Pharmaceutical Industries Limited (TEVA) Stock Analysis
A live, multi-source view of Teva Pharmaceutical Industries Limited (TEVA): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies.
Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic · Israel · 31,173 employees · tevapharm.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Teva Pharmaceutical Industries Limited (TEVA) had a market capitalization of $42.37B, a trailing P/E of 60.6 (forward 11.8) and a beta of 0.87; the shares traded in a 52-week range of $18.21 – $38.37 (88.4% over the year).
- Market cap
- $42.37B
- Enterprise value
- $55.61B
- Trailing P/E
- 60.6
- Forward P/E
- 11.8
- PEG ratio
- 0.67
- Price / book
- 5.47
- EPS (trailing)
- $0.60
- EPS (forward)
- $3.07
- Payout ratio
- 0.0%
- Ex-dividend date
- 2017-11-27
- 52-week range
- $18.21 – $38.37
- 52-week change
- 88.4%
- Beta
- 0.87
- Average volume
- 5.5M
- Shares outstanding
- 1.17B
- Short % of float
- 3.08%
- Profit margin
- 4.1%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Teva Pharmaceutical Industries Limited (TEVA) last closed at $36.35 (the last completed close before that scan).
Technicals at the scan: RSI 51 (neutral territory), price -1.4% versus its 20-day average, 20-day versus 50-day average spread +5.9%, MACD histogram -0.20.
Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 86% bullish; analyst consensus score 81/100.
Next scheduled company event: in 54 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 1 buy and 0 sells of TEVA; corporate insiders filed 0 buys and 4 sells (4 distinct filers, latest disclosure 2026-08-25). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Amir Weiss (0B/2S), Ronit Satchi-Fainaro (0B/1S), Evan Lippman (0B/1S), Alan Armstrong (1B/0S). Who is trading what
RapidTradeView pick record
TEVA has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Teva Pharmaceutical Industries Limited (TEVA) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell TEVA.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.